XYMOGEN EP Exclusive Patented Dietary Supplement Artriphen Clinically Tested to Support Healthy Joint Function

Recall map → All recalls → F-1523-2013

XYMOGEN EP Exclusive Patented Dietary Supplement Artriphen Clinically Tested to Support Healthy Joint Function, 90 and 180 capsule bottles Atlantic Pro Nutrients, Inc. dba XYMOGEN · reported 2013-06-19

Terminated This recall has been closed out by the agency.

Reason for recall: Undeclared Soy and Milk on the label.
Classification: Class I
Recall initiated: 2013-05-01
Reported by the agency: 2013-06-19
Closed out (terminated): 2014-01-15
Recalling firm: Atlantic Pro Nutrients, Inc. dba XYMOGEN
Orlando, FL
United States
This is the firm that issued the recall — commonly a distributor or processor. It is not the origin of contamination.
Distribution (the agency's own words): AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, IL IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NJ, NM, NY, OH, OK, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV, WY, District of Columbia and Hawaii
States we parsed from that text: AK AL AR AZ CA CO CT DC DE FL GA HI IA IL IN KS KY LA MA MD ME MI MN MO MS NC NJ NM NY OH OK PA RI SC TN TX UT VA WA WI WV WY
The agency named these states. Parse method explicit_state_list, confidence high.
Food category: Dietary supplementsderived
Assigned by a reviewed keyword rulebook over the product description, not by the agency.
Recall type: Voluntary: Firm initiated
Recall number: F-1523-2013

This page reproduces a record published by the US Food and Drug Administration. It is not real-time: recalls typically appear in FDA's Enforcement Report weeks after they begin — a median of 40 days, see publication lag. For current food safety information consult FDA and USDA FSIS directly.